Cargando…

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection

Two years after the appearance of the SARS-CoV-2 virus, the causal agent of the current global pandemic, it is time to analyze the evolution of the immune protection that infection and vaccination provide. Cellular immunity plays an important role in limiting disease severity and the resolution of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moga, Esther, Lynton-Pons, Elionor, Domingo, Pere
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271749/ https://www.ncbi.nlm.nih.gov/pubmed/35833134 http://dx.doi.org/10.3389/fimmu.2022.904686

Ejemplares similares

Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
por: Reyes-Leiva, David, et al.
Publicado: (2022)

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection
por: Lin, Jhe-Jhih, et al.
Publicado: (2022)

Cellular immune states in SARS-CoV-2-induced disease
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
por: Qiao, Yidan, et al.
Publicado: (2022)

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
por: Mooij, Petra, et al.
Publicado: (2022)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice
por: Patel, Raj S., et al.
Publicado: (2023)

Complementarity determining regions in SARS-CoV-2 hybrid immunity
por: Frans, Glynis, et al.
Publicado: (2023)

Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients
por: Ni, Ling, et al.
Publicado: (2021)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
por: Mizera, Dorota, et al.
Publicado: (2023)

CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization
por: Haun, Brien K., et al.
Publicado: (2020)

Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
por: Liang, Boyun, et al.
Publicado: (2022)

Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
por: Maaske, Jill, et al.
Publicado: (2023)

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
por: Jay, Cecilia, et al.
Publicado: (2023)

Adaptive Immune Responses and Immunity to SARS-CoV-2
por: Primorac, Dragan, et al.
Publicado: (2022)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Immunity to SARS-CoV-2: Lessons Learned
por: Fergie, Jaime, et al.
Publicado: (2021)

SARS-CoV-2 and the host-immune response
por: Maison, David P., et al.
Publicado: (2023)

SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
por: Jarlhelt, Ida, et al.
Publicado: (2021)

Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
por: Ruhl, Louisa, et al.
Publicado: (2023)

Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design
por: Jaiswal, Varun, et al.
Publicado: (2022)

Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure
por: Neeland, Melanie R., et al.
Publicado: (2021)

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort
por: Vo, Hoa Thi My, et al.
Publicado: (2022)

Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
por: Rice, Adrian, et al.
Publicado: (2022)

Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level
por: Copley, Hannah C., et al.
Publicado: (2021)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge
por: Gary, Ebony N., et al.
Publicado: (2023)

Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2023)

NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines
por: Mueller-Enz, Magdalena, et al.
Publicado: (2023)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain
por: Francistiová, Linda, et al.
Publicado: (2021)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors
por: Kilpeläinen, Athina, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
por: Chu, Chang, et al.
Publicado: (2022)

High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses
por: Akanmu, Sulaimon, et al.
Publicado: (2023)

When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
por: Taoufik, Yassine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9amerahn21slqjbsg8bchscub